Liquidia Corporation
NASDAQ:LQDABiotechnology
Healthcare
$56.63 +0.34%
+$0.23 today
- Market cap
- $5.10B
- Beta
- 0.59
- P/E (TTM)
- 271.8
- EPS (TTM)
- $0.25
52W Low $11.85High $73.22
Volume 1.34M
Average 1.50M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$35.69M
FY 2025 · Annual
Investing Cash Flow
-$6.34M
FY 2025 · Annual
Financing Cash Flow
$59.73M
FY 2025 · Annual
-69.3% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (34.58M) | (41.02M) | (78.5M) | (130.39M) | (68.92M) |
| Depreciation & Amortization | 5.61M | 3.65M | 2.18M | 2.2M | 1.53M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.75M | 9.3M | 10.09M | 18.81M | 29.47M |
| Change in Working Capital | (12.38M) | (2.16M) | 5.87M | (4.79M) | (24.18M) |
| Accounts Receivables | (2.99M) | (2.03M) | 956K | 1.34M | (51.37M) |
| Inventory | 0 | 0 | 0 | (241K) | (22.99M) |
| Accounts Payables | (7.56M) | 814K | (1.15M) | 2.33M | (2.59M) |
| Other Working Capital | (1.83M) | (945K) | 6.07M | (8.22M) | 52.77M |
| Other Non-Cash Items | 566K | 1.64M | 18.8M | 20.76M | 26.42M |
| Operating Cash Flow | (34.04M) | (28.59M) | (41.56M) | (93.42M) | (35.69M) |
| Capital Expenditures | (107K) | (592K) | (1.29M) | (4.95M) | (4.34M) |
| Acquisitions (Net) | 0 | 5K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | (10M) | (3.49M) | (2M) |
| Investing Cash Flow | (107K) | (587K) | (11.29M) | (8.44M) | (6.34M) |
| Debt Repayment | (420K) | 8.96M | 19.37M | 52.5M | 53.82M |
| Common Stock Issued | 21.71M | 54.46M | 24.24M | 138.55M | 4.82M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.03M | 1.55M | (363K) | 3.61M | 1.08M |
| Financing Cash Flow | 26.32M | 64.96M | 43.25M | 194.66M | 59.73M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (3.5M) |
| Net Change in Cash | (7.82M) | 35.79M | (9.6M) | 92.8M | 14.2M |
| Free Cash Flow | (34.14M) | (29.18M) | (42.85M) | (98.37M) | (40.02M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$68.9M
+ D&A$1.5M
+ Stock-Based Comp$29.5M
+ Deferred Tax$0
- Working Capital-$24.2M
+ Other Non-Cash$26.4M
= Operating Cash Flow-$35.7M
- Capex-$4.3M
= Free Cash Flow-$40.0M
Analysis
FY2025 free cash flow is -$40.0M. FCF conversion is 58.1% of net income. Operating cash flow was -$35.7M, with capex of -$4.3M. The largest bridge item is Stock-Based Comp at $29.5M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 8-K | Current report | Oct 14, 2026 |
Does LQDA generate free cash flow?
Liquidia Corporation (LQDA) generated -$40.02M of free cash flow in fiscal 2025.
How much operating cash flow does LQDA produce?
Operating cash flow was -$35.69M, before capital expenditures of $4.34M.
Continue the stock analysis
Jump to another research area for this company.